SHCBP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.581200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.948800E-01
Normal-vs-Stage2
5.371200E-01
Normal-vs-Stage3
4.633000E-01
Normal-vs-Stage4
4.631400E-01
Stage1-vs-Stage2
5.036200E-01
Stage1-vs-Stage3
8.735200E-01
Stage1-vs-Stage4
8.787400E-01
Stage2-vs-Stage3
4.588600E-01
Stage2-vs-Stage4
4.643400E-01
Stage3-vs-Stage4
9.921600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.982600E-01
Normal-vs-AfricanAmerican
5.961800E-01
Normal-vs-Asian
5.543000E-01
Caucasian-vs-AfricanAmerican
9.797400E-01
Caucasian-vs-Asian
3.250200E-01
AfricanAmerican-vs-Asian
3.415200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.754400E-01
Normal-vs-Female
5.891800E-01
Male-vs-Female
2.929400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.559200E-01
Normal-vs-Age(41-60Yrs)
6.496600E-01
Normal-vs-Age(61-80Yrs)
3.796200E-01
Normal-vs-Age(81-100Yrs)
7.038400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.133400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.308000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.664400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.816600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.228400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.545000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.323200E-01
Normal-vs-Daily Drinker
4.268400E-01
Normal-vs-Weekly Drinker
7.951600E-01
Normal-vs-Occasional Drinker
8.134400E-01
Normal-vs-Social Drinker
5.076600E-01
Non Drinker-vs-Daily Drinker
9.558600E-01
Non Drinker-vs-Weekly Drinker
6.746800E-01
Non Drinker-vs-Occasional Drinker
3.785800E-01
Non Drinker-vs-Social Drinker
9.046800E-01
Daily Drinker-vs-Weekly Drinker
6.970800E-01
Daily Drinker-vs-Occasional Drinker
4.211600E-01
Daily Drinker-vs-Social Drinker
9.416200E-01
Weekly Drinker-vs-Occasional Drinker
8.739200E-01
Weekly Drinker-vs-Social Drinker
7.421600E-01
Occasional Drinker-vs-Social Drinker
5.282400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.848800E-01
Normal-vs-Grade 2
6.675800E-01
Normal-vs-Grade 3
7.017600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.648700E-04
Grade 1-vs-Grade 3
4.21809999999745E-05
Grade 1-vs-Grade 4
5.848800E-01
Grade 2-vs-Grade 3
1.399780E-01
Grade 2-vs-Grade 4
6.675800E-01
Grade 3-vs-Grade 4
7.017600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.014000E-01
Normal-vs-NonDiabetic
4.718800E-01
Diabetic-vs-NonDiabetic
9.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.446200E-01
Normal-vs-NoPancreatitis
4.818400E-01
Pancreatitis-vs-NoPancreatitis
8.548200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.322000E-01
Normal-vs-N1
5.238400E-01
N0-vs-N1
6.795000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.687800E-01
Normal-vs-TP53-NonMutant
5.785200E-01
TP53-Mutant-vs-TP53-NonMutant
1.79737000000069E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
